Professor Allison Goldfine: GLP-1 analogues & DPPIV Inhibitors – are there new limits for beneficial cardiovascular outcome in type 2 diabetes?


100/100

Production and streaming of this multimedia archive
is made possible by the kind support of

© Copyright At the Limits Limited 2005 – 2016